Quadrant Capital Group’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Quadrant Capital Group's HALO Position: Q3 2026 in Review
Quadrant Capital Group increased its Halozyme (HALO) stake by 2% in Q3 2026, buying an estimated $17.2K and bringing the position to 8,958 shares worth $982K. The position accounts for 0.03% of the portfolio, ranked #562.
Quadrant Capital Group first reported a position in HALO in Q4 2015 and has held it in 29 quarters since. 313 funds tracked by Wall St. Rank hold HALO as of Q3 2026.
- Quadrant Capital Group held 8,958 shares of Halozyme worth $982K as of Q3 2026.
- Quadrant Capital Group bought 178 Halozyme shares in Q3 2026, an estimated $17.2K.
- Halozyme made up 0.03% of Quadrant Capital Group's portfolio in Q3 2026, its #562 holding.
- Quadrant Capital Group first reported a position in Halozyme in Q4 2015 and has held it in 29 quarters since.
- 313 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.
Based on Quadrant Capital Group's 13F filing for Q3 2026, filed 20 Oct 2026.